Amanta Healthcare Limited Stock Price Today (NSE: AMANTA)

Amanta Healthcare Limited

189.933.87 (2.00%)
Market Closed

Fundamental Score

...

Amanta Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Amanta Healthcare Limited share price today is 189.93, down 2.00% on NSE/BSE as of 16 September 2026. Amanta Healthcare Limited (AMANTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 73.75 (Cr). The 52-week high for AMANTA share price is 209.95 and the 52-week low is 92.00. At a P/E ratio of 45.66x, AMANTA is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 10.39% and a debt-to-equity ratio of 1.06.

Amanta Healthcare Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
205.57
Low
150.01
Volume
1.0L
Change
+23.97%

Amanta Healthcare Limited share price chart: 23.97% return over the past month. 52-week high ₹209.95, 52-week low ₹92.00.

Amanta Healthcare Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
189.93189.93189.93189.9312.45K (Cr)
193.80193.80193.80193.8015.94K (Cr)
197.75197.75197.75197.7519.14K (Cr)
209.95209.95201.78201.7838.22K (Cr)
205.89205.89205.89205.8937.74K (Cr)
201.86201.86201.86201.8650.14K (Cr)
197.91197.91197.91197.9119.41K (Cr)
194.03194.03194.03194.0311.34K (Cr)
190.23190.23190.23190.2319.98K (Cr)
190.00190.00186.50186.5024.02K (Cr)

Amanta Healthcare Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
190.80209.95186.50189.93-0.46%
171.80205.57150.01188.80+9.90%
158.50189.00153.51168.72+6.45%
125.52167.90114.05161.00+28.27%
131.13146.78122.00125.51-4.29%
101.92140.2599.87131.13+28.66%
99.71102.5092.0099.81+0.10%
103.80110.65100.00102.95-0.82%
109.00115.0098.25103.33-5.20%
104.50117.1297.75109.06+4.36%
121.99124.8999.99106.24-12.91%
132.60140.00119.50121.99-8.00%

Returns & Performance

Poor

Return on Equity (ROE)

10.39%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

11.63%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

21.24%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Amanta Healthcare Limited Valuation Check

Poor

Price to Earnings (P/E)

45.66x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

63.56%

% shares held by company founders/management

Poor

FII Holding

0.85%

% shares held by foreign institutional investors

Good

DII Holding

12.88%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-5.61%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

5.35%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.93%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

20.31%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

22.45%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.06x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

2.02x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

128.70 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Amanta Healthcare Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMANTA across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Operating Margins (21.24%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Excellent EPS Growth (20.31% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (22.45% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Healthy Liquidity Position (Current Ratio: 1.69)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹128.70 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (63.56%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Premium Valuation Risk (P/E: 45.66x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Elevated Debt Levels (D/E: 1.06)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (2.02x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Amanta Healthcare Limited vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Amanta Healthcare Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
42.3/100
190
₹73.75
45.7
Average
10.39%
Average
11.63%
Average
1.1
Average
22.45%
Excellent
10.93%
Good
0.00%
66.4/100
1869
₹448453.16
37.1
Average
14.74%
Average
19.31%
Good
0.0
Excellent
31.64%
Excellent
11.78%
Good
0.82%
56.3/100
9494
₹251591.00
86.1
Average
16.19%
Good
20.38%
Excellent
0.0
Excellent
5.29%
Good
8.67%
Good
0.41%
51.4/100
4942
₹167266.93
78.9
Average
27.07%
Excellent
14.09%
Average
1.8
Average
11.56%
Good
11.80%
Good
0.76%
74.1/100
1131
₹112833.88
25.2
Average
19.74%
Good
21.77%
Excellent
0.4
Excellent
18.76%
Excellent
12.45%
Good
0.09%
40.2/100
1372
₹110812.78
32.9
Average
11.82%
Average
15.67%
Good
0.0
Excellent
10.03%
Good
8.01%
Good
0.90%
34.1/100
1934
₹104500.56
95.5
Average
18.19%
Good
21.35%
Excellent
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%
24.6/100
1679
₹96603.91
26.2
Average
9.94%
Poor
14.54%
Average
0.2
Excellent
-8.07%
Poor
6.32%
Good
0.26%
83.4/100
2098
₹95944.77
17.3
Average
26.90%
Excellent
31.80%
Excellent
0.3
Excellent
34.39%
Excellent
13.02%
Good
0.72%
41/100
1144
₹95532.35
29.6
Average
11.75%
Average
14.80%
Average
0.2
Excellent
16.54%
Excellent
12.09%
Good
0.65%
61.5/100
2270
₹93730.35
45.9
Average
12.49%
Average
13.56%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%

Amanta Healthcare Limited Quarterly Performance

Latest quarterly metrics for AMANTA — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

5.35%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-5.61%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.93%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

22.45%

Compounded annual net profit growth over 5 years

Amanta Healthcare Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for AMANTA — calculated from daily price history

67RSI 14
Neutral — RSI 67

Momentum is balanced — neither overbought nor oversold.

SMA 50
174
▲ Price above SMA 50 — Short-term bullish
SMA 200
131
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
80K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Amanta Healthcare Limited Financial Statements

Annual income statement, balance sheet and cash flow for Amanta Healthcare Limited (AMANTA) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Amanta Healthcare Limited

Loading latest quarterly results...

About AMANTA (Amanta Healthcare Limited)

Amanta Healthcar is a global pharmaceutical enterprise committed to advancing health and wellness through the development, production, and distribution of high-quality sterile liqu...id products. They are dedicated to crafting a portfolio of essential pharmaceuticals designed to meet the evolving needs of patients across diverse geographical regions. Amanta's operations are underpinned by a strong commitment to research and development, focusing on innovative formulations and delivery systems to improve therapeutic outcomes. Their core values revolve around safety, efficacy, and accessibility, ensuring that their products reach those who need them most, regardless of their location. Through unwavering dedication to quality and patient-centricity, Amanta strives to be a trusted partner in global healthcare, making a tangible difference in the lives of individuals and communities worldwide. Amanta Healthcar specializes in the manufacture of a comprehensive range of parenteral solutions, meticulously produced under stringent quality control standards. Their state-of-the-art manufacturing facilities are equipped to handle various product formats, catering to the specific requirements of healthcare providers and patients. The company's dedication to sterile manufacturing techniques ensures the safety and integrity of its products, meeting and exceeding international regulatory requirements. Amanta's portfolio includes a diverse array of large-volume parenterals, small-volume parenterals, and specialized delivery systems, such as nipple-head and steriport configurations. This broad product offering positions them as a versatile supplier of essential medications for hospitals, clinics, and other healthcare institutions globally. Amanta Healthcar's commitment extends beyond pharmaceutical manufacturing, encompassing the development and production of critical medical devices and fluid therapies. This expanded focus reflects their understanding of the holistic needs of healthcare providers and their dedication to providing comprehensive solutions. Their fluid therapy segment focuses on intravenous fluids, essential for hydration, electrolyte balance, and medication delivery. By integrating medical devices and fluid therapies into their portfolio, Amanta Healthcar demonstrates a dedication to innovation and comprehensive healthcare solutions. This strategic approach allows them to offer a more integrated and streamlined approach to patient care, further solidifying their position as a valuable partner in the global healthcare landscape.

Company Details

Symbol:AMANTA
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Bhavesh Girishbhai Patel
MD & Chairman
Ms. Nikhita Dinodia
Company Secretary & Compliance Officer
Mr. Shailesh M. Shah
President of Finance

AMANTA Share Price: Frequently Asked Questions

What is the current share price of Amanta Healthcare Limited?

Amanta Healthcare Limited (AMANTA) trades at ₹189.93 on NSE and BSE. Market cap ₹73.75 (Cr). Educational data only.

What is the P/E ratio of Amanta Healthcare Limited?

Amanta Healthcare Limited has a P/E of 45.66x vs industry average 34.89x.

What is the Bull Run score for Amanta Healthcare Limited?

Amanta Healthcare Limited has a Bull Run score of 42.3/100 based on 25+ financial parameters.

Does Amanta Healthcare Limited pay dividends?

Amanta Healthcare Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Amanta Healthcare Limited?

Amanta Healthcare Limited has ROE of 10.39%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Amanta Healthcare Limited?

Amanta Healthcare Limited has debt-to-equity of 1.06.

Is Amanta Healthcare Limited a good investment?

Bull Run gives Amanta Healthcare Limited a score of 42.3/100. This is not investment advice — consult a SEBI-registered advisor.